ESG406
/ Escugen Biotechnology
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 13, 2025
Study of ESG406 in Adults With Solid Tumors
(clinicaltrials.gov)
- P1 | N=556 | Recruiting | Sponsor: Shanghai Escugen Biotechnology Co., Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Oncology • Solid Tumor
May 20, 2025
Study of ESG406 in Adults With Solid Tumors
(clinicaltrials.gov)
- P1 | N=556 | Not yet recruiting | Sponsor: Shanghai Escugen Biotechnology Co., Ltd
New P1 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1